Form 4 for CLPT ClearPoint Neuro, Inc.
Accepted 2024-05-15 00:00:00 ET · period of report 2024-05-14 · accession 0001285550-24-000053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-15 | 2024-05-14 | CLPT | Richards Timothy T. | Dir | M - OptEx | — | +17.2K | 61.6K | +39% | — |
| D | 2024-05-15 | 2024-05-14 | CLPT | Richards Timothy T. | Dir | M - OptEx | $0.00 | -17.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-14 | M | A | 17,153 | — | 61,561 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2024-05-14 | M | D | 17,153 | $0.00 | 0 | D | — · — to — | 17,153 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders. |